Crescent Diagnostics, Ltd.


Osentia® was developed by Crescent Ops Ltd., a UK-based diagnostics company dedicated to early identification of an individuals’ risk of developing osteoporosis effectively.

The development of Osentia® is based upon the pioneering research of Dr Mark Towler, an eminent professor of biomedical engineering while working at the University of Limerick. Dr Towler, who is now based at Ryerson University in Canada, set out to investigate why osteoporosis patients noticed an improvement in their nails when they started treatment for their condition.


64 New Cavendish Street
London, Greater London W1G 8TB

Get Directions

Upgrade Your Listing